+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The role of lipoxygenases in pathophysiology; new insights and future perspectives



The role of lipoxygenases in pathophysiology; new insights and future perspectives



Redox Biology 6: 297-310



Lipoxygenases (LOXs) are dioxygenases that catalyze the formation of corresponding hydroperoxides from polyunsaturated fatty acids such as linoleic acid and arachidonic acid. LOX enzymes are expressed in immune, epithelial, and tumor cells that display a variety of physiological functions, including inflammation, skin disorder, and tumorigenesis. In the humans and mice, six LOX isoforms have been known. 15-LOX, a prototypical enzyme originally found in reticulocytes shares the similarity of amino acid sequence as well as the biochemical property to plant LOX enzymes. 15-LOX-2, which is expressed in epithelial cells and leukocytes, has different substrate specificity in the humans and mice, therefore, the role of them in mammals has not been established. 12-LOX is an isoform expressed in epithelial cells and myeloid cells including platelets. Many mutations in this isoform are found in epithelial cancers, suggesting a potential link between 12-LOX and tumorigenesis. 12R-LOX can be found in the epithelial cells of the skin. Defects in this gene result in ichthyosis, a cutaneous disorder characterized by pathophysiologically dried skin due to abnormal loss of water from its epithelial cell layer. Similarly, eLOX-3, which is also expressed in the skin epithelial cells acting downstream 12R-LOX, is another causative factor for ichthyosis. 5-LOX is a distinct isoform playing an important role in asthma and inflammation. This isoform causes the constriction of bronchioles in response to cysteinyl leukotrienes such as LTC4, thus leading to asthma. It also induces neutrophilic inflammation by its recruitment in response to LTB4. Importantly, 5-LOX activity is strictly regulated by 5-LOX activating protein (FLAP) though the distribution of 5-LOX in the nucleus. Currently, pharmacological drugs targeting FLAP are actively developing. This review summarized these functions of LOX enzymes under pathophysiological conditions in mammals.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 059104813

Download citation: RISBibTeXText

PMID: 26298204

DOI: 10.1016/j.redox.2015.08.006


Related references

Role of microRNAs in cardiac remodelling: new insights and future perspectives. International Journal of Cardiology 167(5): 1651-1659, 2014

The role of transforming growth factor beta in atherosclerosis: novel insights and future perspectives. Current Opinion in Lipidology 13(5): 523-529, 2002

Gastrointestinal food allergy: new insights into pathophysiology and clinical perspectives. Gastroenterology 128(4): 1089-1113, 2005

New insights into the molecular pathophysiology of fragile X syndrome and therapeutic perspectives from the animal model. International Journal of Biochemistry and Cell Biology 53: 121-126, 2015

Transgenic and knockout mice in diabetes research: novel insights into pathophysiology, limitations, and perspectives. Physiology 20: 152-161, 2005

New insights into the pathophysiology of achalasia and implications for future treatment. World Journal of Gastroenterology 22(35): 7892-7907, 2017

Implications and Future Perspectives of AGEs in PCOS Pathophysiology. Trends in Endocrinology and Metabolism: Tem 2019, 2019

Pathophysiology and pharmacotherapy of gastroparesis: current and future perspectives. Expert Opinion on PharmacoTherapy 14(9): 1171-1186, 2013

Hemophagocytic lymphohistiocytosis: diagnosis, pathophysiology, treatment, and future perspectives. Annals of Medicine 38(1): 20-31, 2006

New insights into the pathophysiology of irritable bowel syndrome: implications for future treatments. Current Gastroenterology Reports 7(4): 272-279, 2005

New Insights into the Pathophysiology of Painful Bladder Syndrome: From Humans to Animals and Into the Future. European Urology 70(2): 291-292, 2018

Pathophysiology and Future Therapeutic Perspectives for Resolving Fibrosis in Peyronie's Disease. Sexual Medicine Reviews 2019, 2019

Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet 383(9922): 1068-1083, 2014

Pathophysiology and drug therapy of tardive dyskinesia: current concepts and future perspectives. Drugs of Today 39(1): 19-49, 2003

Recent advances in the research of pathophysiology in inflammatory bowel disease and future perspectives. Nihon Shokakibyo Gakkai Zasshi 115(3): 244-253, 2018